Generx, Inc.
Records under this name other than the patents Generx, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,046,909 | Omega-3 fatty acid ester compositions Lapsed on the fee record Ended Jun 29, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 29, 2025 | From the USPTO record |
| US 10,898,458 | Self-Micellizing Fatty Acids and Fatty Acid Ester Compositions and Their Use in the Treatment of Disease States Lapsed on the fee record Ended Jan 26, 2025 · High confidence | Lapsed on the fee record | Ended Jan 26, 2025 | High confidence |
| US 10,894,027 | Sickle cell disease treatment utilizing omega-3 fatty acids Lapsed on the fee record Ended Jan 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 19, 2025 | From the USPTO record |
| US 9,480,651 | Omega-3 Fatty Acid Ester Compositions Unitary Pharmaceutical Dosage Forms Lapsed on the fee record Ended Nov 1, 2024 · High confidence | Lapsed on the fee record | Ended Nov 1, 2024 | High confidence |
| US 9,375,490 | Stable Micelles of Fatty Acid Esters for the Treatment of Disease States Lapsed on the fee record Ended Jun 28, 2024 · High confidence | Lapsed on the fee record | Ended Jun 28, 2024 | High confidence |
| US 9,370,585 | Stable Micelles of Mixed Fatty Acids Lapsed on the fee record Ended Jun 21, 2024 · High confidence | Lapsed on the fee record | Ended Jun 21, 2024 | High confidence |
| US 9,364,558 | Stable Micelles of Fatty Acid Esters for the Treatment of Cardiovascular Disease Lapsed on the fee record Ended Jun 14, 2024 · High confidence | Lapsed on the fee record | Ended Jun 14, 2024 | High confidence |
| US 9,364,559 | Stable Micelles of Fatty Acid Esters Lapsed on the fee record Ended Jun 14, 2024 · High confidence | Lapsed on the fee record | Ended Jun 14, 2024 | High confidence |
| US 9,364,560 | Stable Micelles of Fatty Acid Esters for the Treatment of Non-Alcoholic Fatty Liver Diseases Lapsed on the fee record Ended Jun 14, 2024 · High confidence | Lapsed on the fee record | Ended Jun 14, 2024 | High confidence |
| US 9,364,561 | Stable Micelles of Fatty Acid Esters for the Treatment of Macular Degeneration and Primary Sclerosing Cholangitis Lapsed on the fee record Ended Jun 14, 2024 · High confidence | Lapsed on the fee record | Ended Jun 14, 2024 | High confidence |